UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016087 |
|---|---|
| Receipt number | R000017750 |
| Scientific Title | Efficasy and safety of bevacizumab in combination with chemotherapy for treating the first recurrence of ovarian carcinoma : Phase 2 study |
| Date of disclosure of the study information | 2015/01/01 |
| Last modified on | 2017/07/14 18:58:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/12/30 15:12:30 | ||
| 2 | Update | 2017/07/14 18:56:22 | Control |
|
| 3 | Update | 2017/07/14 18:57:43 | Name of primary person or sponsor Institute Department Organization |
|
| 4 | Update | 2017/07/14 18:58:39 | Last follow-up date |
